I don't really get what's confusing?
After the existing IP agreements are finished - there are no more (of course we hope that's not the case) - and cash burn is $2mil per Q.
That doesn't include Carslbad manufacturing, sales force commission, shipping etc.
It will take $6,000,000 AUD in product sales to cover costs - the actual profit will be much lower as there will be expenses in getting that product to the marketplace.
As it stands:
The Burnett and Hologic deal covers Q2 cash burn.
To cover Q3 & Q4 we need product sales (as above) or the CR funding will be gone.
Is that clearer mate?
I don't really get what's confusing?After the existing IP...
Add to My Watchlist
What is My Watchlist?
